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Gastroparesia as a frequent complication after extensive left atrial
ablation for atrial arrhythmias: a consecutive series of 100 proce-
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Purpose: Various gastro-intestinal complications have been reported after
atrial fibrillation (Afib) radiofrequency (RF) ablation. The purpose of this
study was to prospectively evaluate the incidence of esogastric injuries after
Afib RF ablation.
Methods: Between June 2007 and April 2009, all patients (pts) in whom
Afib/left atrial flutter RF ablation was performed, underwent a systematic
upper gastro-intestinal endoscopy 24 hours after the procedure. Endoscopic
findings were classified as likely related to the procedure, potentially related
or unrelated.
Results: 100 ablation procedures were performed in 77 pts using a 4
mm irrigated-tip RF catheter with temperature set to 45°C. Ablation con-
sisted in antral isolation of pulmonary veins (PVI) in 63 cases (63%; max-
imum power: 30W), associated with creation of roof and left isthmus lines
in 14 (14%;35W), and additional left atrial fragmented electrograms abla-
tion in 23 (23%;35W). Esogastric endoscopy found gastroparesia in 6
cases (6%), considered as likely related to the ablation and due to vagal
injury. Among these cases, 4 had left atrial fragmented electrograms abla-
tion (p<0.001). In 3 PVI cases (3%), localized esophagus erythema was
also considered as likely related to the ablation procedure. In 5 cases with
either Mallory Weiss-like syndrome (n=3) or circumferential esophagus
erythema (n=2), RF induced lesions could not be fully ruled out. In 3
cases, esophageal lesions were likely due to pre-operative trans-esophageal
echocardiography (2 hematomas and 1 proximal ulceration). In 45 cases
(45%), endoscopic abnormalities were considered as unrelated to the abla-
tion (gastritis, n=18; Barret’s esophagus, n=7; hiatal hernia, n=14). Endo-
scopy was normal in 43 cases (43%).
Conclusions: In this prospective study, the incidence of asymptomatic eso-
gastric injuries likely related to RF ablation was fairly high (9%). Gastro-
paresia was the main complication and was significantly associated with
extensive left atrial ablation.
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Long-term monitoring of 340 patients with a cardiac resynchroniza-
tion therapy: comparing CRT-P and CRT-D and evaluation of res-
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The main objective of this retrospective study is to analyze the future of
heart failure patients, refractory to optimal pharmacological treatment,
implanted by a system of bi-ventricular pacemaker (CRT-P) or defibrillator
(CRT-D).
Methods: 340 patients were implanted between the 1st January 1999 and
31 December 2007, aged 69 +/-10 years mainly men (80%). The total popula-
tion presented in part ischemic heart disease (56%), NYHA class III (79%)
and an indication of primary prevention (76%). The number of hospitalization
in the 6 months prior to implantation is an average of 1 +/-1. The population
was divided into 3 groups: 
Group 1: 49 patients implanted with a CRT-P before March 2003, 
Group 2: 84 patients implanted with a CRT-P after March 2003, 
Group 3: 207 patients implanted with a CRT-D after March 2003.
Results: For all 3 groups combined rate of responders was 75%, with a
reduction in particular, the NYHA class (p <0.001), number of hospitalizations
(p <0.001) and an increasing LVEF (p <0.001).
The curves of Kaplan-Meyer shows that there is a significant difference
between curves CRT-P and CRT-D curve, with a survival rate higher with the
CRT-D (Logrank:: Group1 vs. Group 3 p <0.01 and Group 2 vs Group 3
p<0.05).
Discussion: Treatment with bi-ventricular stimulation shows that 75% of
patients are improved compared to the criteria usually measured. It appears
that treatment with CRT-D provides a survival rate more important for a pop-
ulation significantly younger (66 +/-10 years).
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Prevalence and Risk Factors Related to Infections of Cardiac Resyn-
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Khriss, Karl Isaaz
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Background: Device related infections [DRI] are not well understood
in patients implanted with a cardiac resynchronization therapy [CRT]
device.
Objectives: The aim of this study was twofold: [1] to evaluate the prev-
alence of CRT DRI; [2] to analyze the predictive factors of CRT DRI.
Methods and Results: From January 2001 to May 2007, CRT implanta-
tion was obtained in 303 pts. The mean follow-up was 31±19 months. Pop-
ulation characteristics were: mean age of 70±10 years old; 56 female;
aetiology [202 dilated and 101 ischemic cardiomyopathy]; NYHA class
3.2±.3; LVEF [26±6%]; QRS [171±31] ms. Thirteen patients developed a
DRI: endocarditis in 4, pocket erosion in 3, pocket abscess in 5 and septi-
caemia in 1. The prevalence of DRI was 4.3%. By univariate analysis, pre-
dictive factors of DRI were: procedure time [skin to skin: median of 85 vs.
57.5 min; p=. 03], reintervention [54% vs. 6.5%; p <. 0001], hematoma
[31% vs. 8.6% p=. 01], lead dislodgment [23% vs. 6.2%; p=. 03], dialysis
[23.1% vs. 1.72%; p=. 003] and procedure type [CRT ICD [8.6%] vs. CRT
PM [1.6%] or up-grading procedure [1.5%]; p=. 03]. Four independent pre-
dictive factors of DRI were identified: procedure time [p=. 0002]; dialysis
[p=. 001]; reintervention [p=. 006] and procedure type [CRT ICD vs. other
procedures; p=. 01].
Conclusions: This study found that the prevalence of CRT DRI is close
to 4.3% at 2.6 years [1.7% per year incidence]. Four independent predic-
tive factors of infections were identified including reintervention, proce-
dure time, dialysis, and primo CRT-ICD implantation. These parameters
should be part of the risk-benefit evaluation in patients selected for CRT’s
implantation.
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Follow-up of Brugada syndrome patients without implantable cardio-
verter-defibrillator: the “Achilles’ heel” of current studies?
Florence Arsac, Frederic Sacher, Nicolas Derval, Pierre Jais, Meleze
Hocini, Philippe Ritter, Pierre Bordachar, Sylvain Ploux, Antoine Depla-
gne, Jacques Clementy, Michel Haissaguerre
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Risk stratification for sudden cardiac death in asymptomatic Brugada syn-
drome (BS) patients is not perfect. Although follow-up of patients with an
implantable cardio-defibrillator (ICD) is reliable, follow-up for patients
without an ICD is less accurate.
Method: All patients seen at the Bordeaux CHU between 1999 and 2009
with BS (spontaneous type 1 or after flecainide or ajmaline test) were included
prospectively in the database, i.e. 187 patients (76 % men, 44 ±12 years).
Follow-up of non-implanted patients was carried out by consultation or annual
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telephone contact. All patients seen over the last 6 months were recontacted
for this study.
Results: One hundred and two patients (55% BS, 76 % men, 43 ±13 years)
did not have an ICD. In 50 % of cases the BS had been discovered by chance,
after lipothymia or syncope in 32% of cases and during family assessment in
18 % of cases. A spontaneous type 1 was present in 68 %. Electrophysiolog-
ical Study (EPS) had been carried out in 79% of patients (Negative in 75 pts
and positive in 5pts who had refused the ICD).
Average follow-up was 52 ±37 months, and no subject was lost to follow-
up (follow-up<6months for all patients), 89 were asymptomatic, 7 presented
with lipothymia, 1 with syncope (without arrhythmia on loop recorder), 1 had
supra-ventricular tachycardia and 3 had died (septic shock, overdose, and one
young patient called in for a family assessment died suddenly, even though his
EPS was negative).
Conclusions: After an exhaustive 4.3 year follow-up, 3/102 patients with
BS and with no ICD had died, 1 suddenly, despite following risk stratification
recommendations.
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Background: The diagnosis of Brugada Syndrome (BS) is typically
made in a young otherwise healthy population. In patients with high risk of
sudden cardiac death (SCD), the only recommended therapy is an implant-
able cardioverter defibrillator (ICD), but this can lead to complications. Pre-
vious studies have shown that the rate of complication related to ICD is
important in this population because young and socio-professionally active.
The remote monitoring may simplify or improve their follow-up by checking
daily the device system.
Methods: Thirty-five consecutive patients (26 males, 44±11) were
implanted for BS with an ICD with a remote monitoring system (Home Mon-
itoring (HM) Biotronik). They were matched for age, sex and follow-up dura-
tion with 35 BS patients implanted with an ICD without this capability.
Results: During a mean follow-up of 2,5 years, the use of remote monitoring
reduced significantly by 67% the number of cardiology consultations (3 ±2 vs 7
±3, p<0,001). The HM system induces an economy of 192  per patient per year.
Half of the HM patients (48%) had moved to consult only one or twice during
this follow-up. So they can maintain a social and professionnal normal life.
In the HM group, inappropriate shocks were less frequent than in the con-
trol group (4 vs 6) although without significant difference (p=0,48). Seventy-
three alerts were transmitted by the remote monitoring or 0,07 alerts per
patient per month representing a workload of 3.5 hours per 100 patients per
year. This early detection of abnormality may have prevented one or several
inappropriate shocks in 11% of HM patients by prompt reprogramming of the
devices.
Conclusion: Remote monitoring simplifies the follow-up of these young
otherwise healthy patients by decreasing significantly the number of cardi-
ology consultations. Remote monitoring optimizes the follow-up with early
detection of failures that could potentially be complicated by inappropriate
shocks.
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Complete atrioventricular block during ablation of atrial flutter. Inci-
dence and causes
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Ahmed Abdelaal, Simona State, Daniel Beurrier, Fabrice Duhoux
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Radiofrequency (RF) ablation of typical atrial flutter (AFl) is largely used
to restore and maintain a sinus rhythm. Little is known on the risk of a third
degree atrioventricular block (AVB). The purpose of the study was to evaluate
the incidence and the causes of iatrogenic complete AVB during RF ablation
of a typical AFl.
Population: AFl ablation was performed in 763 patients (pts), 606 males,
157 females aged from 18 to 90 years (64±12) with recurrent or bad–tolerated
typical AFl; 330 pts had associated significant heart disease (valvular 68, con-
genital 24, ischemic heart disease 71, dilated cardiomyopathy 43, miscella-
neous 78) or chronic pulmonary disease (46).
Methods: AFl RF catheter ablation was performed by conventional method
with setting a HALO catheter in coronary sinus and using an 8-F quadripolar
with an 8 mm-tip electrode catheter; a maximum power of 70 w and a max-
imum target temperature of 70° was used. Obtaining a sinus rhythm and a
complete isthmus block was the objective of the procedure.
Results: Complete AVB (1 %) was noted when sinus rhythm was
restored, in 8 pts aged from 59 to 89 years (73±9) significantly older than
other pts (63.5±12) (p <0.02): 2 AVB’s were accidental, related to His
bundle damage and remained permanent; 2 AVB’s were regressive and
related to a traumatic block in pts with left bundle branch block; one AVB
disappeared after interruption of class I antiarrhythmic drug; 3 AVB’s were
of ischemic origin in pts with known coronary heart disease; in 2 of them
ST segment elevation and AVB resolved with antithrombotic therapy; in one
59 year old man, AVB was related to an acute occlusion of the segment 3
of the right coronary artery. His recanalization by initial balloon angioplasty
and stent implantation was associated with the immediate restoration of a
normal AV conduction.
Conclusions: Complete AVB was a rare complication of RF ablation of
typical atrial flutter (1 %) which concern old pts; it is significantly more fre-
quent in pts with ischemic heart disease (3/71, 4 %) than in pts without
ischemic disease (p<0.05). This ischemic AVB is regressive after the imme-
diate treatment of acute coronary syndrome.
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Cardiac pacemaking involves several ion channels, which are subtly regu-
lated by autonomic nervous system. The hyperpolarization-activated cyclic
nucleotide gated channel, particularly HCN4 subunit, is considered as a major
actor for sino-atrial node automaticity. Moreover due to its directly regulation
by cAMP, HCN4 channels have been proposed as one of the main responsible
for the increase of heart rate after sympathetic stimulation. However its rela-
tive importance remains highly controversial.
To investigate the role of HCN channel in cardiac automaticity and sympa-
thetic regulation, we used telemetric ECG recording techniques in two specific
mouse strains: one with a conditional complete suppression of HCN4 conduc-
tance (HCN4-AYA) and the second with a loss of cAMP-mediated modulation
of HCN4 (HCN4-CNBD).
Our results show that in the two strains heart rate is reduced by the same
percentage with respect to the wild type. During pharmacological sympathetic
stimulation the maximal heart rate was lower in the two transgenic strains
than in wild type, but the relative extent of heart rate remains the same for all
mice.
Our data confirm the importance of HCN4 for cardiac pacemaking both at
rest and during sympathetic stimulation, and that the presence of cAMP is
essential for HCN4 function. Moreover, our results seem to indicate that this
channel is not indispensible for heart rate autonomic regulation.
